Characterization of N+R@PLT activation behavior

The activation behavior of PLTs was analyzed by TEM and FCM. After activation, PLTs were centrifuged, and the supernatant was analyzed by FCM. The nanoplatelets were labeled with an anti-CD62P Cy5.5 antibody.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.